Feedback from group discussions

1
Feedback from group discussions

• Cancer Prevention Research Network
• Launch Workshop
• Sept 2007
• Network website
• www.ihs.manchester.ac.uk/ResearchNetworks/Preventi
  oncancer/

2
Prevention community

• Current situation
• Difficulty of finding relevant funding
• Funding limited for prevention work relative to
  other areas of funding
• Lack of evidence
• Skill mix
• Who benefits?

3
Funding

• Lack of obvious route
• Commercial too long term
• DH
• Overseas?
• Possible routes?
• Food stds agency
• Framework 7
• CRUK?
• DTI / Medical insurers
• Commercial HR benefits

4
Lack of evidence

• Knowledge of side effects
• Behaviour
• Environment
• Drugs
• Epidemiological
• Intervention side effects
• Very few studies (to our knowledge)
• Quackery
• Anecdotal
• Side effects?
• There are opportunities for our Network

5
Who should be involved?

• Intervention (Level) (The research community)
• Clinician
• Epidemiologists
• Behaviour scientists
• Drug groups trials units
• Nutritionists
• Basic science e.g. biomarker end points /
  predictors of cancer
• Health promotion/Social Marketing
• Statisticians Health Economists
• Public Health
• The Public Public Bodies
• Mass Media/Internet
• Biomarkers and imaging
• Politicians
• Social Scientists
• Web sites

6
Who benefits / should be involved?

• Public / patient representative
• Public policy
• Education
• Social economic policy
• Environment
• Local authority
• Toxicology / molecular epidemiologists

7
Start up / Infrastructure funding

• Pilot data
• Biomarker identification
• Partnerships
• Maintain capabilities
• Population / patient databases
• Id high risk populations / groups

8
What is the scope of the cancer prevention
research network?

• Facilitator Alison Wearden

9

• Purpose of network is to foster research
  collaborations between scientists working on
  different cancers and coming from different
  disciplines
• Therefore felt that scope of network should be
  kept as broad as possible

10

• Should screening research and research on genetic
  predisposition be within scope of network?
• Yes assume that scope goes beyond primary
  prevention
• Screening can inform prevention at different
  stages eg HPVI
• Importance of interaction of different risk
  factors need to talk to each other

11
Activities of network

• Research collaboration, sharing resources and
  expertise
• Education and publicity
• Updated website, searchable by expertise and
  specialism
• Meet twice per year different disciplines give
  over view of what they are doing
• Patient involvement

12
A cancer prevention network?Challenges for the
future and how can we solve them?
13
Challenges

• Funding
• Boundaries
• Intellectual, geography etc
• Prevention primary secondary tertiary?
• Prevention where is the endpoint
• Behaviour change!!
• Which behaviours?
• Scale of studies
• Sites and Silos
• Useful interventions (priorities)
• Strengths and weaknesses in GM
• Population, Multiple Trusts, Universities and
  disciplinary mix
• The public patient issue

14
Network will help

• Have you met anyone you didnt know before whom
  you might work with?
• Cancer geneticist GSOH WLTM Health economist for
• Communication
• Institutions (from Cochrane to Paterson)
• Have you had an idea you hadnt had before?
• Network to develop it
• Have you identified a funding source you hadnt
  thought of before?
• A conduit and strength (you are not alone)

15
Actions

• Equity map!
• Bang for buck
• Prioritise a quick win for the network!
• Future network meetings on themes
• Identify funding approach
• Asset audit

16
(No Transcript)